GlassScriptPhysician profile
Raj Patel
NPI 1710417902
$455.47
in general payments reported to CMS, 2019-2025
9 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $183 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $256.96 | 2022-2023 | Indigo System |
| Boston Scientific Corporation | $43.77 | 2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Pulmonx Corporation | $32.26 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Eisai INC. | $28.82 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.97 | 2025 | |
| Veryan Medical Incorporated | $20.54 | 2023 | Biomimics 3d Vascular Stent System |
| Astrazeneca Pharmaceuticals LP | $17.88 | 2025 | Imfinzi |
| Terumo Medical Corporation | $16.27 | 2025 | Glidesheath Slender, Angio-Seal |
| Dexcom, INC. | $14.00 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.